These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 1384333)

  • 1. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
    Williams MA; Hickok DE; Zingheim RW; Luthy DA; Kimelman J; Nyberg DA; Mahony BS
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1032-7. PubMed ID: 1384333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease.
    Dinglas C; Afsar N; Cochrane E; Davis J; Kim S; Akerman M; Wells M; Chavez M; Herrera K; Heo H; Vintzileos A
    Am J Obstet Gynecol; 2020 May; 222(5):499.e1-499.e6. PubMed ID: 31794723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
    Simpson JL; Palomaki GE; Mercer B; Haddow JE; Andersen R; Sibai B; Elias S
    Am J Obstet Gynecol; 1995 Dec; 173(6):1742-8. PubMed ID: 8610755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
    Kuo PL; Lin CC; Lin YH; Guo HR
    J Formos Med Assoc; 2003 May; 102(5):319-25. PubMed ID: 12874670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
    Konchak PS; Bernstein IM; Capeless EL
    Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoprotein.
    Simpson JL; Elias S; Morgan CD; Andersen RN; Shulman LP; Sibai BM; Mercer BM; Skoll A
    Am J Obstet Gynecol; 1991 Mar; 164(3):829-36. PubMed ID: 1706141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
    Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI
    Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications.
    Waller DK; Lustig LS; Cunningham GC; Feuchtbaum LB; Hook EB
    Obstet Gynecol; 1996 Nov; 88(5):816-22. PubMed ID: 8885920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental pathology at term associated with elevated midtrimester maternal serum alpha-fetoprotein concentration.
    Salafia CM; Silberman L; Herrera NE; Mahoney MJ
    Am J Obstet Gynecol; 1988 May; 158(5):1064-6. PubMed ID: 2453114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin.
    Alkazaleh F; Chaddha V; Viero S; Malik A; Anastasiades C; Sroka H; Chitayat D; Toi A; Windrim RC; Kingdom JC
    Am J Obstet Gynecol; 2006 Mar; 194(3):821-7. PubMed ID: 16522419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexplained elevations of maternal serum alpha-fetoprotein.
    Katz VL; Chescheir NC; Cefalo RC
    Obstet Gynecol Surv; 1990 Nov; 45(11):719-26. PubMed ID: 1700347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia.
    Spong CY; Ghidini A; Walker CN; Ossandon M; Pezzullo JC
    Am J Obstet Gynecol; 1997 Nov; 177(5):1085-7. PubMed ID: 9396898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
    Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
    J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
    Williams MA; Hickok DE; Zingheim RW; Mittendorf R; Kimelman J; Mahony BS
    Obstet Gynecol; 1992 Nov; 80(5):745-9. PubMed ID: 1383900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonographic investigation of placental morphologic characteristics and size during the second trimester of pregnancy.
    Jauniaux E; Ramsay B; Campbell S
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):130-7. PubMed ID: 7507643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
    Huerta-Enochian G; Katz V; Erfurth S
    Am J Obstet Gynecol; 2001 Jun; 184(7):1549-53; discussion 1553-5. PubMed ID: 11408879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of midtrimester maternal serum alpha-fetoprotein are associated with preterm delivery but not with fetal growth retardation.
    Davis RO; Goldenberg RL; Boots L; Hoffman HJ; Copper R; Cutter GR; DuBard MB; Cliver SP; Smith RK
    Am J Obstet Gynecol; 1992 Sep; 167(3):596-601. PubMed ID: 1382388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation.
    Salafia CM; DeVore GR; Mainolfi E; Kelly J; Pezzullo JC; Rothlein R
    Am J Obstet Gynecol; 1993 Oct; 169(4):830-4. PubMed ID: 7694462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
    Toal M; Chaddha V; Windrim R; Kingdom J
    J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.